|Treatment of edema (swelling due to fluid retention, which is often associated with congestive heart failure and kidney failure) and hypertension (usually in combination with other drugs). Classification: diuretic.|
|Treatment of hypertension and edema. Classification: combination of two diuretics.|
Calan: Treatment of angina (chest pain), hypertension and certain arrhythmias (irregular heart beat). Classification: calcium channel blocker.
Calan SR: Treatment of hypertension, with a sustained-relief formulation that allows once-a-day dosing. Classification: long-acting calcium channel blocker.
|Treatment of hypertension and angina. COER-24 delivery system is designed to align treatment with the body's natural circadian rhythms. Classification: long-acting calcium channel blocker.|
|Treatment of hypertension. Classification: beta blocker.|
|Treatment of documented, life-threatening ventricular arrhythmias (irregular heart beat). Controlled-release (CR) formulation allows twice-a-day dosing.|
|Dietary supplement that replenishes magnesium levels in the body. Available without a prescription.
(zolpidem tartrate) CIV
|Short-term treatment of insomnia.|
|Treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis. Classification: nonsteroidal anti-inflammatory drug (NSAID).|
|Prevention of gastric ulcers caused by use of nonsteroidal anti-inflammatory drugs (NSAIDs), the most common medications for treating arthritis symptoms.|
Treatment of certain anaerobic bacterial infections, including trichomonas vaginalis, a common gynecologic infection. 375 mg dosage form allows medication to be taken twice a day rather than three times.
(ethynodiol diacetate with ethinyl estradiol)
Norinyl® 1 + 50
|Oral contraceptives for the prevention of pregnancy.|
|Nasal spray for the treatment of endometriosis (a growth of tissue outside of the uterus), which often causes pain and infertility.|
|Treatment of osteoarthritis and adult rheumatoid arthritis. Combines diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), with misoprostol, which helps protect against NSAID-induced gastric ulcers. New drug application filed with U.S. Food and Drug Administration December 1995.|
Next stop on the guided tour is the press releases section or or pick the path you want to follow: